EMEA-001532-PIP01-13

Key facts

Active substance
  • Ertugliflozin
  • Metformin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0054/2014
PIP number
EMEA-001532-PIP01-13
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc. 
Belgium 
E-mail: pip.information@merck.com 
Tel. +31 412663179 
Fax +31 412662571
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating